LIQUIDIA CORPORATION's ticker is LQDA and the CUSIP is 53635D202. A total of 32 filers reported holding LIQUIDIA CORPORATION in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $9,321,000 | -43.3% | 1,894,471 | -2.9% | 0.09% | -47.6% |
| Q2 2020 | $16,431,000 | +110.4% | 1,951,455 | +17.7% | 0.17% | +65.0% |
| Q1 2020 | $7,811,000 | +10.2% | 1,658,485 | 0.0% | 0.10% | +63.5% |
| Q4 2019 | $7,090,000 | +24.8% | 1,658,485 | +4.0% | 0.06% | +10.5% |
| Q3 2019 | $5,679,000 | -48.2% | 1,595,283 | +16.4% | 0.06% | -45.7% |
| Q2 2019 | $10,961,000 | -27.2% | 1,370,074 | +3.5% | 0.10% | -26.1% |
| Q1 2019 | $15,065,000 | -1.9% | 1,323,792 | +86.7% | 0.14% | -11.8% |
| Q4 2018 | $15,359,000 | -17.0% | 709,077 | +5.2% | 0.16% | +3.9% |
| Q3 2018 | $18,496,000 | – | 674,283 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Square Capital LP | 7,182,532 | $86,190,384 | 40.01% |
| Caligan Partners LP | 10,360,945 | $124,331,340 | 29.05% |
| FINDELL CAPITAL MANAGEMENT LLC | 2,400,000 | $28,800,000 | 13.89% |
| Whitefort Capital Management, LP | 774,479 | $9,293,748 | 5.73% |
| HARBERT FUND ADVISORS, INC. | 339,158 | $4,069,896 | 2.89% |
| LB Partners LLC | 282,947 | $3,395,364 | 2.83% |
| FINDELL CAPITAL MANAGEMENT LLC | 400,000 | $4,800,000 | 2.32% |
| Vestal Point Capital, LP | 1,830,000 | $21,960,000 | 1.64% |
| Kepos Capital LP | 200,000 | $2,400 | 0.93% |
| Opaleye Management Inc. | 325,000 | $3,900,000 | 0.89% |